Chemoinformaics analysis of digitoxigenin 3-O-[beta-D-glucosyl-(1->4)-alpha-L-acofrioside]
| Molecular Weight | 696.831 | nRot | 7 |
| Heavy Atom Molecular Weight | 640.383 | nRig | 37 |
| Exact Molecular Weight | 696.372 | nRing | 7 |
| Solubility: LogS | -3.086 | nHRing | 3 |
| Solubility: LogP | 1.67 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 49 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
| nHA | 13 | APOL | 107.886 |
| nHD | 6 | BPOL | 67.4636 |
| QED | 0.204 |
| Synth | 5.69 |
| Natural Product Likeliness | 2.408 |
| NR-PPAR-gamma | 0.341 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.036 |
| Pgp-sub | 0.042 |
| HIA | 0.98 |
| CACO-2 | -5.748 |
| MDCK | 0.0000737 |
| BBB | 0.079 |
| PPB | 0.930169 |
| VDSS | 0.631 |
| FU | 0.0727926 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.372 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.217 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.199 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.083 |
| CL | 0.824 |
| T12 | 0.049 |
| hERG | 0.151 |
| Ames | 0.079 |
| ROA | 0.982 |
| SkinSen | 0.023 |
| Carcinogencity | 0.042 |
| EI | 0.003 |
| Respiratory | 0.91 |
| NR-Aromatase | 0.837 |
| Antiviral | Yes |
| Prediction | 0.848034 |